Viking Therapeutics stock tumbled after the drugmaker released study results of its experimental weight-loss pill.

A late-stage trial shows a daily pill helped people lose 12% of their body weight—without injections. You have two coins that ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.

VK2735 met its primary endpoint but failed to outdo competitors Novo Nordisk and Eli Lilly in terms of body weight loss.

Viking Therapeutics' stock crashed 40% in early trading on Tuesday after a phase 2 trial of its weight-loss pill showed a ...

Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage ...

Viking Therapeutics said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a ...

Viking Therapeutics’ VK2735 achieves a 10.9% placebo-adjusted weight loss at 13 weeks, but a less than ideal safety profile ...

A doctor has explained how the body adjusts to the weight-loss drug Mounjaro during its first month of use. Weight loss drugs ...

A Shropshire GP has said many patients are worried about having to stop their weight loss journey as the cost of Mounjaro is ...